Systemic effects of salbutamol and salmeterol in patients with asthma

Bennett, J A; Smyth, E T; Pavord, I D; Wilding, P J; Tattersfield, A E
August 1994
Thorax;Aug1994, Vol. 49 Issue 8, p771
Academic Journal
No abstract available.


Related Articles

  • Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Smyth, E.T.; Pavord, I.D.; Wong, C.S.; Wisniewski, A.F.Z.; Williams, J.; Tattersfield, A.E.T. // BMJ: British Medical Journal (International Edition);2/27/93, Vol. 306 Issue 6877, p543 

    Examines the pharmacological interaction of salmeterol and salbutamol on patients with asthma. Effect of adding salbutamol to salmeterol on patients; Potency of salmeterol over salbutamol; Comparison of daily equivalent dosage.

  • Effect of Salmeterol Is independent of Previously Inhaled Salbutamol: A Clinical Controlled Study. Wilcke, J.T.R.; Iversen, E.T.; Kok-Jensen, A. // Lung;1998, Vol. 176 Issue 2, p133 

    Examines the bronchodilating effect of an inhaled long acting beta[sub 2]-agonist (salmeterol) after a high dose of an inhaled short acting beta[sub 2]-agonist (salbutamol) in asthma patients. Additive effect of combining salbutamol and salmeterol; Absence of an effect of inhaled salbutamol on...

  • Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Castle, Win; Fuller, Rick; Hail, John; Palmer, James // BMJ: British Medical Journal (International Edition);4/17/93, Vol. 306 Issue 6884, p1034 

    Examines the safety of salmeterol and salbutamol in treating asthma in Great Britain. Use of inhale beta agonist as the most effective bronchodilator; Non-fatal events related to asthma experience by treated patients; Association between treatment and incidence of deaths.

  • Salbutamol/salmeterol/fluticasone propionate.  // Reactions Weekly;5/3/2008, Issue 1200, p27 

    The article describes the case of a 49-year-old woman who developed uncontrolled asthma while receiving salbutamol, salmeterol and fluticasone propionate. The result of the respiratory examination performed on the patient is presented. Information on the dosage and duration of salbutamol,...

  • Comparison of the Bronchodilator Effect of Inhaled Short- and Long-Acting β-Agonists in Children with Bronchial Asthma: A Randomised Trial. Verini, M.; Verrotti, A.; Greco, R.; Chiarelli, F. // Clinical Drug Investigation;1998, Vol. 16 Issue 1, p19 

    Objective: This study compared the bronchodilator effects of short-acting (salbutamol and procaterol) and long-acting (salmeterol and formoterol) β-agonists in children with bronchial asthma. Patients: Twenty-seven (18 male, 9 female) children with bronchial asthma were enrolled in the study....

  • Comparison of intravenous aminophylline and salbutamol in severe asthma. Femi-Pearse, D.; George, W.O.; Ilechukwu, S.T.; Elegbeleye, O.O.; Afonja, A.O. // British Medical Journal;2/19/1977, Vol. 1 Issue 6059, p491 

    Compares the intravenous aminophylline with salbutamol in patients with severe asthma, a common respiratory emergency treated in Great Britain. Dosages of aminophylline and salbutamol; Effectiveness of intravenous salbutamol in treatment of asthma; Characteristics of patients in the study.

  • Responses to a beta-agonist after salmeterol treatment. Pinkowish, Mary Desmond // Patient Care;9/30/1995, Vol. 29 Issue 15, p98 

    Reports briefly on the study to assess the effects of salmeterol on the acute effects of the bronchodilator salbutamol by researchers at the University of Dundee, Scotland. Original publication titled,` Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic...

  • Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma. Cates, C. J. // Evidence Based Medicine;Feb2009, Vol. 14 Issue 1, p6 

    The article presents a review on the daily salmeterol increases non-fatal serious adverse events in chronic asthma. The review analyzes the effect of the daily salmeterol in the chronic asthma patients. Studies compared salmeterol with placebo or short-acting ß-antagonists in patients with...

  • Salbutamol/salmeterol.  // Reactions Weekly;11/28/2009, Issue 1280, p40 

    The article describes the case of a 47-year-old man who developed dilated cardiomyopathy and died from heart failure while undergoing treatment with salbutamol and salmeterol for symptoms of asthma. The patient has chronic obstructive airway disease and pneumothorax. It had been assumed that the...

  • Salmeterol/fluticasone cost effective in asthma in Canada.  // PharmacoEconomics & Outcomes News;Sep2014, Vol. 711 Issue 1, p30 

    The article reports on the cost-effectiveness of Salmeterol/fluticasone propionate in treating patients with uncontrolled asthma in Canada.


Read the Article


Sign out of this library

Other Topics